TELESTA THERAPEUTICS INC T.TST

New coverage out

[simouuun]

Just received this via newsletter lads:

TST.CN: Sleeper North of the Border with Priority Review; Initiating at Buy, 12-Mo.Price Target$1.50


[url=https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=html&co=Roth2&id=[e-mail]&source=mail&pdfFileExtension=.pdf]https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=html&co=Roth2&id=[e-mail]&source=mail&pdfFileExtension=.pdf[/url]

[noinstinct89]

[url=https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=pdf&co=Roth2&id=[e-mail]&source=mail]https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=pdf&co=Roth2&id=[e-mail]&source=mail[/url]

[1wascallywabbit]

TST.CN: Sleeper North of the Border with Priority Review; Initiating at Buy   We are initiating coverage of Telesta with a Buy rating and $1.50 price target. We believe Telesta has flown under the radar in Canada and the U.S. with a mixed company history. Fast forward to significantly streamlined operations, and importantly, Priority Review granted by the FDA for MCNA use in bladder

[1wascallywabbit]

Note the Disclosures; (Bold is mine) Disclosures: Within the last twelve months, ROTH has received compensation for investment banking services from Telesta Therapeutics Inc. (OTC: BNHLF). ROTH makes a market in shares of Telesta Therapeutics Inc. (OTC: BNHLF) and Endo Pharmaceuticals Holdings and as such, buys and sells from customers on a principal basis

[1wascallywabbit]

Better Link? https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=html&co=Roth2&id=[e-mail]&source=mail&pdfFileExtension=.pdf

[givmeabrake]

Can you please re-post . That link seems encrypted.

[BeenHereBefore]

That's not a link. Links do something when you click them. THIS is a link: [url=https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=pdf&co=Roth2&id=[e-mail]&source=mail]https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=pdf&co=Roth2&id

[BeenHereBefore]

Piece of shhit Stockhouse! https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb-b006b9503f82&mime=pdf&co=Roth2 BeenHereBefore wrote: That's not a link. Links do something when you click them. THIS is a link: [url=https://roth2.bluematrix.com/sellside/EmailDocViewer?encrypt=6bfa69fa-faf3-435d-bfdb

[givmeabrake]

Price target $1.50  USD   HUGE!!! $1.95 CAD ehh!

[1wascallywabbit]

Where do you see that the target is $1.50 USD. Everything else on the report is in cdn$, so why wouldn't the Target be the same?

[HighteawithIntrepid]

I think the $1.50 is a conservative NPV best guess so 1 year out the 1.50 could be a lot more because  they are factoring a discount for a possible no. I would think if we get an ADCOM yes the value would  increase enough to make their 1.50 CDN 1.50 US. HT

[DamnYankees]

the new analyst coverage was well received, trading red to end the day on Banhelef. the only people buying on the basement of the pinks are doing so on the way to or from their bookmaker. Let's  concede that no effort will be put into moving the share price and get the 15 for 1 outta the way. Oh, and I am happy to see that "failed to meet its end points" is becoming almost as

[cheetio]

The Saviours Reverse split Vision once the trading price of the Common Shares is greater than $1.50, the Common Shares will be eligible for margin lending by investment dealers in Canada.............1.50 hey target

[DamnYankees]

great Point Cheet. analyst report still implies huge risk. Just like the shelf financing held back the SP the supposed consolidation is doing the same. Most of them end badly, very badly. A positive  Adcomm won't do much of anything until the 15 for 1 is done and the Xmas option festival is out of the way. shareholders should have clued into theiR position on the totem pole by now but